Machine Learning

Panorama Education launches AI-powered tutoring and career tools, promising personalized student support while navigating the complex landscape of data privacy.

A new US-Korean deal aims to solve the biggest hurdle for next-gen EV batteries: mass production. Can they win the high-stakes global battery race?

Broadcom ships a revolutionary 2nm chip with 3.5D 'face-to-face' stacking, promising unprecedented power and efficiency for the next generation of AI.

As AI hiring tools face scrutiny for bias, WorkWhile's new platform uses AI to uncover worker skills and build careers, not just screen applicants.

New TPRY fund offers retail access to David Tepper's strategy plus a high-income options play, but does the reward outweigh the inherent risks?

Flexport launches a suite of AI tools to audit customs, optimize shipping, and process tariff refunds, aiming to create a fully autonomous supply chain.

The Singaporean facilities firm lands major residential deals, bolstering its recurring revenue as it navigates financial headwinds with a push in AI robotics.

A consulting firm's work optimizing ORs and sterile processing impacted over 1 million patients, revealing the crucial link between logistics and patient care.

Nautilus Biotechnology cuts losses and preps its Voyager platform for a late 2026 launch, targeting the next frontier in neurodegenerative disease research.

A new partnership brings AI to customs, promising to help U.S. importers reclaim millions in overpaid duties and navigate volatile global trade.

Spectral Medical shifts its FDA submission for a breakthrough sepsis device, a strategic move that could strengthen its case but delays a potential lifeline.

Robert Herjavec invests in AI firm Lovelytics, betting on the critical need for data infrastructure and aiming to scale the top Databricks partner.

As a 24-year CEO era ends, McCoy Global bets on an internal tech architect to lead its future in automated well construction and maintain growth.

Romania's new 1,500km quantum network, powered by IonQ, marks a major step in Europe's race to secure critical data against future cyber threats.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.

Former USAA CEO Wayne Peacock joins Cotality's board, signaling a strategic push to lead the AI-driven property data and insurance analytics market.

With a key FDA decision looming and pivotal data on a second therapy imminent, Viridian is poised to reshape the multi-billion dollar Thyroid Eye Disease market.

After a strong 2025, Viatris unveils a plan for $650M in savings, a 10% workforce cut, and a focus on six new drugs to fuel future innovation.

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.